Company news
Puretech Health Plc (LSE:PRTC) news
Puretech Health Plc news releases on 6ix. Latest, Mar 18, 2019: Karuna Announces $68 Million Series B Financing
Press releases — page 8
Karuna Announces $68 Million Series B Financing
March 18, 2019
Akili & Shionogi Deal in Taiwan/Japan $20M upfront
March 7, 2019
Karuna Appoints Chief Financial Officer
March 5, 2019
PRTC to Present at Two US Investor Conferences
February 21, 2019
Vor Raises $42M to Advance Leukaemia Treatment
February 14, 2019
Alivio Partners to Advance Non-opioid Pain Therapy
January 28, 2019
Vedanta Immuno-oncology Candidate Published
January 23, 2019
Vedanta Biosciences Raise $27M Series C Financing
December 24, 2018
Vedanta Initiates Phase 2 Study for Lead Candidate
December 17, 2018
Vedanta & BMS Immuno-Oncology Collaboration
December 10, 2018
Vor Granted First-in-class Immuno-oncology Patent
November 28, 2018
Janssen/Vedanta Phase 1 in IBD & $12M Milestone
November 27, 2018
Full Gelesis Data Published in the Journal Obesity
November 13, 2018
PRTC to Present at Jefferies 2018 in London
November 7, 2018
Vedanta Presents Data on Immuno-Oncology Candidate
November 6, 2018
Gelesis to Present Full Data for Lead Candidate
November 5, 2018
Karuna Adds Sage Therapeutics CEO to Board
October 17, 2018
resTORbio Announces Additional Positive Ph 2b Data
October 16, 2018
Karuna Initiates Phase 2 Study in Schizophrenia
October 15, 2018
Vedanta Announces Successful Ph1 Clinical Results
October 4, 2018
Brain Lymphatics Published in Nature Neuroscience
September 17, 2018
Akili Exclusively Licenses New Digital Technology
September 12, 2018
PureTech Health plc - Half-Year Report
September 11, 2018
Vedanta Adds Fmr Janssen Immunology Head to Board
September 5, 2018
PureTech's Karuna Appoints Steven Paul, MD, as CEO
August 15, 2018
PureTech's Akili Expands Series C Funding to $68M
August 9, 2018
PureTech's Karuna Completes $42M Financing
August 2, 2018
Brain Lymphatics Programme Published in Nature
July 26, 2018